ADDENDUM – NCCAM EXPLORATORY/DEVELOPMENTAL GRANT FOR CLINICAL STUDIES
(R21) PAR-03-153
RELEASE DATE: February 5, 2004
NOTICE: NOT-CA-04-006
National Cancer Institute (NCI)
(http://www.nci.nih.gov)
This addendum is to inform potential applicants that the National
Cancer Institute is co-sponsoring this announcement PAR-03-153
(http://grants.nih.gov/grants/guide/pa-files/PAR-03-153.html) and is
interested in research applications that focus on complementary and
alternative medical approaches related to the prevention, diagnosis,
and treatment of cancer as well as to the management of cancer symptoms
and side effects due to conventional cancer treatment.
Applicants are encouraged to review the most recent NCI Plan and Budget
Proposal for additional information about topics that are of program
relevance to the NCI. These documents are available at
http://cancer.gov/publications, by email at cisocc@pop.nci.nih.gov, or
by telephone at 1-800-4-CANCER and are published each year. The
document for fiscal 2004: “The Nation’s Investment in Cancer Research:
A Plan and Budget Proposal for Fiscal Year 2004” is NIH Publication No.
03-4373.
Applicants are also encouraged to review the topics that have been
processed through the NCI’s Best Case Series program. For additional
information, see http://www.cancer.gov/cam or contact Dr. Wendy Smith
(see below).
INQUIRIES
Inquiries regarding this notice may be directed to:
Wendy B. Smith, Ph.D.
Program Director, Research Development and Support Program
Office of Cancer Complementary and Alternative Medicine
National Cancer Institute
6130 Executive Blvd, EPN Suite 102, MSC 7302
Bethesda, Maryland 20892-7302
Rockville, MD 20852 (for express/courier service)
Telephone: 301-435-7980
FAX: 301-480-0075
Email: smithwe@mail.nih.gov